US Patent Issued to Eli Lilly and Co. on May 26 for "Antibodies that bind human and mouse INSL5 and encoding nucleic acids thereof" (American, Danish Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,508, issued on May 26, was assigned to Eli Lilly and Co. (Indianapolis).

"Antibodies that bind human and mouse INSL5 and encoding nucleic acids thereof" was invented by Petra Verdino (San Diego) and Hsiu-Chiung Yang (Smorum, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds and methods targeting insulin-like peptide-5 (INSL5), including antibodies, cells and vectors comprising DNA encoding the same, and methods for producing the antibodies. In addition, the present invention provides for use of INSL5 antibodies in diagnostic assays."

The patent was filed on Aug. 3, 2021, under Application No. 18/006,169....